🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to superstar co-fellows Anne Knisely, MD & Alexa Kanbergs on SGO FWC research awards!!! Way to make cancer history!!@MDAndersonNews Proud 🙌 #SGO2024

Hear Núria Agustí Garcia, of MD Anderson Cancer Center, preview her #SGOMtg presentations on the MELISA trial in ovarian cancer, as well as fertility-sparing surgery & brachytherapy boost in cervical cancer. See our site for Dr Agusti's insights and more! SGO #gyncsm onclive.com/conference/sgo

At the #SGOMtg, we sat down with @naomi_adjeimd, of MD Anderson Cancer Center, to discuss opportunistic salpingectomy for ovarian cancer primary prevention. Thanks for sharing your insights, Dr Adjei! See our site for more! @sgo_org #gyncsm onclive.com/conference/sgo

Great presentation by Dr Fernandez MD Anderson Cancer Center SGO on tumor microenvironment in obese patients with #endometrialcancer #SGOMtg

Congratulations to Anne Knisely, MD Amir Jazaeri MD Anderson Cancer Center on this impactful work evaluating prognostic markers of MRD and ctDNA in #ovariancancer #SGOMtg #oncsurgery

Translational biomarkers of response to Enzalutamide in #endometrialcancer presented by Anil Sood MD Anderson Cancer Center #SGOMtg

Grateful for the opportunity to learn from this group of visionary leaders and collaborators! Thanks to SGO! MD Anderson Cancer Center Break Through Cancer #SGO2024

Counting my blessings, starting with these gems from Yale ObGyn Residents at #SGO2024 SGO

Ovarian cancer is deadly, costly, and impacts overall QOL. Primary prevention via opportunistic salpingectomy is cost-effective and safe. Thanks to my mentors and SGO for the opportunity to discuss our work. #SGO2024 📸Dana Hazimeh

Hear Naomi Adjei, MD, MPH, MSEd, of MD Anderson Cancer Center, preview her #SGOMtg presentation on opportunistic salpingectomy for ovarian cancer prevention! Check out our site for more #gyncsm updates! SGO onclive.com/conference/sgo

Impactful work by superstar cofellow Dr. Amma Asare and Anil Sood! Identifying predictors for the development of MDS/AML among patients who receive PARPi will inform patient selection and strategies for mitigating risks. #SGO2024 SGO MD Anderson Cancer Center

Counting my blessings with these gems from MD Anderson Cancer Center GYN ONC #SGO2024 #disco SGO

Your legacy is for life! Thank you for making room for all of us! Your bravery, vulnerability and generosity have inspired me. Thank you Dr. Frumovitz MD Anderson Cancer Center SGO #SGO2024

Practice changing work by Anne Knisely, MD and Nicole D. Fleming MD! Apixaban should be standard of care for VTE prophylaxis for GYN cancer patients. Importantly, we have to make apixaban affordable for all patients. MD Anderson Cancer Center SGO #SGO2024

#SGOMtg Poster session coming up at 11:45am…. Make sure you check out the awesome work by our fellow Dr Allison Brodsky combining the PI3K inhibitor, copanlisib, with the PARPi, niraparib! 🔥⭐️🙌 #gyncsm

👏👏👏Congratulations to Naomi Adjei, MD, MPH, MSEd who knocked it out of the park presenting on opportunistic salpingectomy at the #SGOMtg. Our MD Anderson Cancer Center fellows are working to #endcancer #gyncsm Larissa Meyer

American Society of Preventive Oncology (ASPO) ASPO Disparities Special Interest Group #aspo2024 Community&science session! Our invited community leaders &COE moderators- where the work gets done&we should center! @equalhope_il Peer Plus Joanne G. Joanne Glenn ; Juanita a. ellastrp.org Key advice to share!

Thankful to Pamela T. Soliman MD MD Anderson Cancer Center for the opportunity to engage in strategic planning sessions with key stakeholders from 🇬🇭 and 🇺🇸 to address barriers to cancer care across various disease sites at the Ghana Physicians and Surgeons Foundation on Modern Cancer Care in 🇬🇭

First clinical trial in Ghana: A study of sequential epirubicin and docetaxel/capecitabine in locally advanced breast cancer - Ghana/Mayo partnership 2002 led by Dr. Alex Adjei, Chief, Cancer Institute Cleveland Clinic GPSF 🇬🇭

Dr. Frumovitz has made an incredible impact in #gynonc, both as a gifted educator & researcher. Consider a gift to honor his contributions to our field & support his research in the treatment of rare #gyn cancers. mdanderson.donordrive.com/index.cfm?fuse… Michael Frumovitz MD Anderson Cancer Center SGO